156 related articles for article (PubMed ID: 10997127)
1. Mild cognitive impairment. When is it a precursor to Alzheimer's disease?
Shah Y; Tangalos EG; Petersen RC
Geriatrics; 2000 Sep; 55(9):62, 65-8. PubMed ID: 10997127
[TBL] [Abstract][Full Text] [Related]
2. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
3. Mild cognitive impairment.
Aggarwal NT
Panminerva Med; 2007 Dec; 49(4):183-9. PubMed ID: 18091670
[TBL] [Abstract][Full Text] [Related]
4. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?].
Sarazin M; Dubois B
Rev Neurol (Paris); 2002; 158(10 Suppl):S30-4. PubMed ID: 12529583
[TBL] [Abstract][Full Text] [Related]
5. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
Small BJ; Gagnon E; Robinson B
Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
[TBL] [Abstract][Full Text] [Related]
6. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
Hansson O; Buchhave P; Zetterberg H; Blennow K; Minthon L; Warkentin S
Neurobiol Aging; 2009 Feb; 30(2):165-73. PubMed ID: 17646035
[TBL] [Abstract][Full Text] [Related]
7. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.
Visser PJ; Verhey FR
Psychol Med; 2008 Jan; 38(1):113-22. PubMed ID: 17451628
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in preclinical Alzheimer's disease.
Chong MS; Lim WS; Sahadevan S
Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
[TBL] [Abstract][Full Text] [Related]
9. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
Clément F; Belleville S; Gauthier S
J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
[TBL] [Abstract][Full Text] [Related]
10. Predictors of progression from mild cognitive impairment to Alzheimer disease.
Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
[TBL] [Abstract][Full Text] [Related]
11. EEG synchronization likelihood in mild cognitive impairment and Alzheimer's disease during a working memory task.
Pijnenburg YA; v d Made Y; van Cappellen van Walsum AM; Knol DL; Scheltens P; Stam CJ
Clin Neurophysiol; 2004 Jun; 115(6):1332-9. PubMed ID: 15134700
[TBL] [Abstract][Full Text] [Related]
12. [Alzheimer drugs for mild cognitive impairment].
Fellgiebel A
Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
[TBL] [Abstract][Full Text] [Related]
13. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
[TBL] [Abstract][Full Text] [Related]
14. Facial emotion recognition deficit in amnestic mild cognitive impairment and Alzheimer disease.
Spoletini I; Marra C; Di Iulio F; Gianni W; Sancesario G; Giubilei F; Trequattrini A; Bria P; Caltagirone C; Spalletta G
Am J Geriatr Psychiatry; 2008 May; 16(5):389-98. PubMed ID: 18403572
[TBL] [Abstract][Full Text] [Related]
15. [Mild cognitive impairment].
Perneczky R; Alexopoulos P; Kurz A
MMW Fortschr Med; 2004 Sep; 146(38):34-7. PubMed ID: 15532428
[TBL] [Abstract][Full Text] [Related]
16. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
[TBL] [Abstract][Full Text] [Related]
17. Prospects of genetic research of mild cognitive impairment.
van Duijn CM
J Intern Med; 2004 Sep; 256(3):235-9. PubMed ID: 15324366
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment.
Tang-Wai DF; Knopman DS; Geda YE; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Boeve BF; Petersen RC
Arch Neurol; 2003 Dec; 60(12):1777-81. PubMed ID: 14676056
[TBL] [Abstract][Full Text] [Related]
19. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
[TBL] [Abstract][Full Text] [Related]
20. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
